
Sign up to save your podcasts
Or


Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
276276 ratings
Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

321 Listeners

701 Listeners

504 Listeners

299 Listeners

260 Listeners

906 Listeners

3,374 Listeners

1,150 Listeners

518 Listeners

367 Listeners

12 Listeners

18 Listeners

15 Listeners

9 Listeners

260 Listeners

437 Listeners

320 Listeners

46 Listeners

14 Listeners

325 Listeners

270 Listeners